Abstract

Prednisolone given universally for COPD exacerbations causes harm without any benefit. Patients deserve blood eosinophil-guided prednisolone treatment for COPD exacerbations.

Document Type

Editorial

Date of Publication

1-1-2023

Volume

9

Issue

5

Publication Title

ERJ Open Research

Publisher

European Respiratory Society

School

School of Medical and Health Sciences

Funders

AstraZeneca

Creative Commons License

Creative Commons Attribution 4.0 License
This work is licensed under a Creative Commons Attribution 4.0 License.

Comments

Ramakrishnan, S. (2023). Prednisolone for COPD exacerbations: time for a rethink. ERJ Open Research, 9(5). https://doi.org/10.1183/23120541.00464-2023

Included in

Diseases Commons

Share

 
COinS
 

Link to publisher version (DOI)

10.1183/23120541.00464-2023